Patents expiring in 2030

US 7645441

Compositions and methods in cancer associated with altered expression of PRLR

Sagres Discovery, Inc. · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7645732

Treating hepatitis C virus infection

The Board of Regents of the University of Texas System · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7645876

Processes for producing crystalline macrolides

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7645789

Indole derivatives as CFTR modulators

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7645881

Methods for treating hepatitis C

PTC THERAPEUTICS, INC. · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7645885

Non-steroidal antiandrogens

The Regents of the University of California · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7645775

Triazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7648826

Detecting CYP24 expression level as a marker for predisposition to cancer

The Regents of the University of California · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7648994

Heterocyclic cyclopamine analogs and methods of use thereof

Infinity Discovery, Inc. · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7648701

Peptide composition as immunogen for the treatment of allergy

United Biomedical, Inc. · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7649088

Atlastin

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7648695

Medicaments for chemotherapeutic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7649098

Imidazole-based compounds, compositions comprising them and methods of their use

LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7649028

Interim dental dressing and restorative material

United States of America as represented by the Secretary of the Air Force · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7649080

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7649115

MAO-B inhibitors useful for treating obesity

Jenrin Discovery, LLC · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7649001

Fused benzene derivative and use

Takeda Pharmaceutical Company Limited · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7652035

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7652133

Indole compound

Takeda Pharmaceutical Company Limited · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7652077

Graft prosthesis, materials and methods

Cook Regentec LLC · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7652001

Pharmacologically active agents containing esterified phosphonates and methods for use thereof

The Regents of the University of California · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7652135

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7651707

Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome

The Regents of the University of California · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7652153

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7651845

Method and apparatus for glucose control and insulin dosing for diabetics

The Regents of the University of California · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7651847

Methods of oligosaccharide profiling for the detection of cancer

The Regents of the University of California · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7651701

Bone cement composition and method of making the same

Sanatis GmbH · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655781

Variants of human glycoprotein hormone alpha chain: compositions and uses thereof

Protalix Ltd. · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655685

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Jenrin Discovery, LLC · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655797

Intermediates for making 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655621

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655247

Malaria vaccines

The Government of the United States, as Respresented by the Secretary of the Army · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655695

Illudin analogs useful as anticancer agents

The Regents of the University of California · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655752

TNF-α converting enzyme inhibitory agents and method of using same

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655241

Methods and compositions for vaccination against or involving enterobacteriaceae bacteria

The Board of Regents of the University of Texas System · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655472

Treatment of disease by inducing cell apoptosis

The Regents of the University of California · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655758

Stable liquid IL-1 antagonist formulations

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655252

Antimicrobial nanoemulsion compositions and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655474

Trioxyethylene gold nanoclusters functionalized with a single DNA

United States of America as represented by the Secretary of the Air Force · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655762

Monoclonal antibodies against ANGPTL4

LEXICON PHARMACEUTICALS, INC. · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655397

Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655694

Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655747

Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution

Nektar Therapeutics · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655722

Adhesive composition

Kuraray Medical Inc. · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7655665

Nitromethylene derivatives and their use

East China University of Science and Technology · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659403

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659283

Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659267

1,3-Benzothiazinone derivatives, process for producing the same use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)